Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanisław Surma

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Medicina (Kaunas, Lithuania)|October 28, 2023
Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver DiseaseAleksandra Bołdys, Łukasz Bułdak, Mateusz Maligłówka, et al.
Journal of Clinical Medicine|January 8, 2023
Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of DyslipidemiaBożena Sosnowska, Weronika Adach, Stanisław Surma, et al.
Cardiology Journal|October 13, 2021
Colchicine - From rheumatology to the new kid on the block: Coronary syndromes and COVID-19Stanisław Surma, Marcin Basiak, Monika Romańczyk, et al.
Journal of Cardiovascular Development and Disease|March 28, 2023
The Effect of a Vegan Diet on the Cardiovascular SystemMichail Koutentakis, Stanisław Surma, Sylwester Rogula, et al.
Frontiers in Nutrition|June 6, 2022
Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most?Stanisław Surma, Amirhossein Sahebkar, Jakub Urbański, et al.
Cardiology Journal|August 1, 2022
Coffee and cardiac arrhythmias: Up-date review of the literature and clinical studiesStanisław Surma, Monika Romańczyk, Krzysztof J Filipiak, et al.
Journal of Cardiovascular Development and Disease|November 24, 2023
The Ketogenic Effect of SGLT-2 Inhibitors-Beneficial or Harmful?Michail Koutentakis, Jakub Kuciński, Damian Świeczkowski, et al.
International Journal of Environmental Research and Public Health|July 9, 2022
What Is or What Is Not a Risk Factor for Arterial Hypertension? Not Hamlet, but Medical Students Answer That QuestionTomasz Sobierajski, Stanisław Surma, Monika Romańczyk, et al.
Frontiers in Public Health|April 13, 2026
Population-level evidence on lifestyle-related education and preventive services in primary care in Poland-a 2025 cross-sectional surveyJustyna Grudziąż-Sękowska, Kuba Sękowski, Mateusz Jankowski, et al.
Nutrients|July 30, 2025
The Visceral Adiposity Index and Its Usefulness in the Prediction of Cardiometabolic DisordersGrzegorz K Jakubiak, Georgian Badicu, Stanisław Surma, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Medicina (Kaunas, Lithuania)|October 28, 2023
Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver DiseaseAleksandra Bołdys, Łukasz Bułdak, Mateusz Maligłówka, et al.
Journal of Clinical Medicine|January 8, 2023
Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of DyslipidemiaBożena Sosnowska, Weronika Adach, Stanisław Surma, et al.
Cardiology Journal|October 13, 2021
Colchicine - From rheumatology to the new kid on the block: Coronary syndromes and COVID-19Stanisław Surma, Marcin Basiak, Monika Romańczyk, et al.
Journal of Cardiovascular Development and Disease|March 28, 2023
The Effect of a Vegan Diet on the Cardiovascular SystemMichail Koutentakis, Stanisław Surma, Sylwester Rogula, et al.
Frontiers in Nutrition|June 6, 2022
Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most?Stanisław Surma, Amirhossein Sahebkar, Jakub Urbański, et al.
Cardiology Journal|August 1, 2022
Coffee and cardiac arrhythmias: Up-date review of the literature and clinical studiesStanisław Surma, Monika Romańczyk, Krzysztof J Filipiak, et al.
Journal of Cardiovascular Development and Disease|November 24, 2023
The Ketogenic Effect of SGLT-2 Inhibitors-Beneficial or Harmful?Michail Koutentakis, Jakub Kuciński, Damian Świeczkowski, et al.
International Journal of Environmental Research and Public Health|July 9, 2022
What Is or What Is Not a Risk Factor for Arterial Hypertension? Not Hamlet, but Medical Students Answer That QuestionTomasz Sobierajski, Stanisław Surma, Monika Romańczyk, et al.
Frontiers in Public Health|April 13, 2026
Population-level evidence on lifestyle-related education and preventive services in primary care in Poland-a 2025 cross-sectional surveyJustyna Grudziąż-Sękowska, Kuba Sękowski, Mateusz Jankowski, et al.
Nutrients|July 30, 2025
The Visceral Adiposity Index and Its Usefulness in the Prediction of Cardiometabolic DisordersGrzegorz K Jakubiak, Georgian Badicu, Stanisław Surma, et al.
Pageof 7